March 2017 Newsletter


What is a Domain Task Force?

The CTSA Consortium has restructured its organizational, operational and communication structure to be more strategic and project driven, rather than committee driven. The reorganization has resulted in five Domain Task Forces (DTFs) which are aligned with the goals and priorities of the NCATS Advisory Council Working Group, NCATS, and NIH. 

The DTFs will:
  • provide direction for CTSA projects
  • focus on short and long term needs to advance translational research
  • provide structure for high priority issues
  • support an inclusive and transparent process where CTSA Hubs can participate and have access to information
  • foster communication and collaboration at all levels
  • define objectives, timelines, and deliverables for every activity 
The first task force is focused on Collaboration/Engagement . The main objective of this DTF is to make sure stakeholders are engaged in collaborations to advance translation. Next, there is an Informatics DTF which aims to support researchers in their use of modern informatics methodologies and techniques in their clinical and translational research. The Integration Across the Lifespan Domain Task Force is focused on the integration of multiple phases and disciplines across the lifespan of a translational study.  The DTF, Methods/Processes , is aimed more towards how translational research works. The Methods/Processes Domain Task Force will be studying how translational research is conducted and will develop ways to improve the process. The final DTF, Workforce Development , will advance translational discoveries by promoting translational research as a field.
For more information on Domain Task Forces visit:

Congratulations to the November 2016 CTSC Core Utilization Pilot Awardees!

Nathan Berger, MD
Case Western Reserve University School of Medicine
"Diet Induced Obesity and Hepatocellular Cancer in Female Mice"

Maya Breitman, PhD
MetroHealth Medical Center
"Cell Based Therapy in Rheumatoid Arthritis: Managing the Epigenome"

Jignesh Dalal, MD
University Hospitals Cleveland Medical Center
"Analysis of Outcomes in Patients with Aplastic  Anemia"

Alvin Schmaier, MD
University Hospitals Cleveland Medical Center
"Preventing Ponatinib-Induced Thrombosis"

Congratulations to the January 2017 CTSC Core Utilization Pilot Awardees!

Chao-Pin Hsiao, PhD
Case Western Reserve University School of Nursing
"Mitochondrial Gene Expression, Mitochondrial Bioenergetics, and Fatigue in Patients with Prostate Cancer"

Jason Mears, PhD
Case Western Reserve University School of Medicine
"Probing the Drp-1Mff Interaction Interface Using X-Ray Footprinting"

Folashade Otegbeye, MD, MPH
University Hospitals Cleveland Medical Center
"Do Changes in Killer-cell Immunoglobulin-like Receptor Phenotype of Circulating Natural Killer Cells Following Hypomethylation Therapy Correlate with Treatment Response in AML/MDS?"

The Federal Government has released their final major changes to the Final Rule on Federal Policy for the Protection of Human Subjects, also known as the "Common Rule." For a brief summary please  click here.

The Health and Medicine Counsel of Washington (HMCW) are currently accepting feedback from CCTS members about the changes to the Common Rule, and the measures taken to address community concerns raised by the proposed rule. Feedback can be submitted to Dane Christiansen at .

Researchers: Pure Experts can connect you with other researchers!

In an effort to promote multi-disciplinary clinical and translational research, the Clinical and
Translational Science Collaborative of Cleveland (CTSC) is pleased to introduce Pure Experts, a directory of researcher expertise that enables collaboration among researchers.

This expertise portal is a key component of the CTSC's mission to catalyze new knowledge  and discovery to enhance and improve patient care and promote better health in the  community.

Pure allows you to:
  • Capture and structure your research data centrally
  • Identify funding, expertise and collaborative partners
  • Report on the reliable, validated data
  • Analyze the progress of your teams and departments
  • Showcase your accomplishments
For more information about Pure, please see the Pure Brochure.

Do you know the difference between a PMID and a PMCID?

A PMID, also known as the PubMed reference number, is a number assigned by the NIH National Library of Medicine to papers indexed in PubMed.

The PMC reference number (PMCID) is assigned when the article is posted on PubMed Central. It is the proof of compliance that you must include when submitting applications, proposals, and reports to the NIH.

Have questions? Need help? Contact the CTSC at

View the full compliance checklist for submitting a manuscript.

PRCHN News  from the PRCHN 
PRCHN Seminars

Mark your calendars for these upcoming PRCHN Seminars.

3/8/17 - 
Ohio Tobacco Trends and Policy
Amy Bush Stevens, Health Policy Institute of Ohio

4/12/17 - 
Tobacco Retailer Density and Proximity to Schools: Associations with Lower Product Pricing and Increased Marketing
Andrew Arnesetti-Rothermel, PhD, MPH; Truth Initiatives

You can find more information on these seminars and other PRCHN programs   here.
For more news from PRCHN check out their e-newsletter!

New Demonstration Grant Will Address Tobacco Disparities

PRCHN Associate Director Erika Trapl, PhD
"Associate Director Erika Trapl, PhD, is the principal investigator on a one-year tobacco disparities demonstration grant from the Ohio Department of Health. One of the unique aspects of the grant is that it extends work in which the PRCHN is currently engaged as a partner of the Health Improvement Partnership-Cuyahoga (HIP-Cuyahoga) and Healthy Cleveland. Building on the Resident Team model developed by HIP-C, the Tobacco Disparities Project will utilize a multi-level approach to tobacco prevention and cessation. These strategies will be underpinned by a culturally informed media messaging campaign to raise awareness of dangers of tobacco, particularly cigar products, and encourage smoking cessation."

Apply Now for a Summer Internship with the PRCHN!

The PRCHN Internship Program aims to give student interns the experience to pursue a career in public health through developing core public health practice skills. Each intern will work specifically on one project covering a current health problem during their internship. They will also get to experience an overview of the research and methods used by the center. Each intern will participate in approximately 120 hours of work during their internship.

Additionally, there are a limited number of paid internships available which are specifically tied to one project and which may require more hours.

For more information go to the PRCHN Website.

Urbanhealth News from the Urban Health Initiative
Urban Health Initiative News
Register now for CTRL+ALT+CLE, Cleveland's version of the Open Data Day events going on across the country.

The Urban Health Initiative is involved with three sessions on March 2:
At 9:00 am, Health Data Matters co-Director, Dr. Scott Frank will lead Data Visualization 101.  Participants will have the opportunity to create compelling, interactive infographics, stories and maps with data on health determinants and outcomes for Cleveland and Cuyahoga County neighborhoods. 
At 11:30 am, Urban Health Initiative Executive Director Amy Sheon will lead a panel discussion on the relationship between digital inclusion and health equity.  The session will feature School of Medicine faculty member Adam Perzynski, Samantha Schartmant from Connect Your Community, and Leon Wilson, Chief of Digital Innovation for the Cleveland Foundation.
At 1:30 pm, Amy Sheon and Becky Gawelek from the Cuyahoga County Board of Health will lead a hands on workshop to help participants explore the contributions of social determinants of health to health disparities.  Participants will use the Health Data Matters Live Stories platform, the CDC's 500 Cities Project and the Federal Communication Commission's Mapping Broadband Health platform.
Data Days continues on March 3, with a Keynote address at the City Club by Aneesh Chopra, the nation's first Chief Technology Officer, and concludes with an "un/conference" Saturday.  That day, participants will shape the sessions based on responses to brief "lightening talks" given by invited speakers.  Amy Sheon and Scott Frank will give a lightening talk related to open data for health.
The complete schedule for Data Days can be found here:
Finally,  Health Data Matters has integrated a very significant new resource into both of its platforms ( and census-tract level estimates for chronic disease risk factors, health outcomes and clinical preventive service use in Cleveland.  By combining this informaiton with data on the social determinants of health already on our site, visitors have very powerful new tools for understanding and addressing health disparities.
Some illustrations follow:
Obesity Prevalence Among Adults Aged 18+ Years in Cleveland and the United States. 

And then look at the association between obesity prevalence and diabetes prevalence by census tract, and the prevalence of multiple adverse health outcomes by census tract:

We look forward to helping you use this data to benefit your own research and teaching!

Urbanhealth News from our Colleagues
2017 Bioethics Conference: Ethics of Integrating Research and Clinical Care
March 23-24, 2017

The bioethics community is gathering again this spring in Cincinnati for the conference  Ethics of Integrating Research and Clinical Care, March 23-24, 2017. 
The conference will be hosted by the Cincinnati CTSA: Center for Clinical & Translational Science & Training (CCTST). P resentations by Scott Kim, MD, PhD, NIH Dept. of Bioethics; Andrew Mulberg, MD, Amicus Therapeutics (former Deputy Director of FDA); and Kevin Weinfurt, PhD, Duke University School of Medicine will be given at the event.
Online registration  is now open.  For more information, see details below, visit the conference homepage   or contact event chair Richard Ittenbach, PhD.

Brian Werbel Memorial and Cancer Center Summer Training Program for Medical Students

The Case Comprehensive Cancer Center is looking for medical students interested in summer research opportunities. 

There are 9 openings available, with 5 supported by the Brian Werbel Memorial Fund and 4 by the Case Comprehensive Cancer Center.

  • Completed application and reference letter due by: Friday, March 31, 2017
  • Awardees must be conducting cancer research with a Case Comprehensive Cancer Center member
  • Those receiving the Brian Werbel Memorial Fund awards must attend the annual golf outing. 
For more details and an application, contact Damian Junk:

The Case Comprehensive Cancer Center (Case CCC) is a partnership of the Case Western Reserve University School of Medicine, the Seidman Cancer Center of University Hospitals Case Medical Center of Cleveland, and the Taussig Cancer Institute of the Cleveland Clinic. Through the collaborative research activities of the partner institutions, the Case CCC pursues its mission of translating research discoveries into improved treatments for cancer patients throughout the region and nation.Visit us on the web at

The Brian Werbel Memorial Fund, established in 2007 at University Hospitals Cleveland Medical Center, is dedicated to providing summer fellows an opportunity to focus on cancer research, with the ultimate goal to aid in curing cancer. Brian's hope was to find a cure for cancer --to make a difference in the world, just as he made a difference in the lives of everyone he touched.Learn More about Brian's Hope for the Future:

Research Research Highlights
Prostate Cancer Research Uses Team Science to Find New Identification Process

Anant Madabhushi and collaborators have identified a new method of recognizing prostate cancer. The team used MRI to study 70 individuals, and noticed a pattern of shape in their images. MRI scanners differ in pixel intensity between models which can cause discrepencies when diagnosing prostate cancer by other methods. However, the shape of the prostate stays constant between machines, making it a more reliable biomarker for prostate cancer. For better reliablility, t he method would be combined with a complimenting test to assign a cancerous label to tissues.  The information used in the research came from 5 institutions located around the world,  and consistently  showed differences between cancerous and non-cancerous tissues. 

The lead researcher on the project is Anant Madabhushi, who was awarded a CTSC Annual Pilot award and has written many papers on biomedical improvements in identifying prostate cancer. Vikas Gulani, a former KL2 Scholar, is additionally listed as a collaborator and author on this paper. 

CWRU Researchers Receive $2 Million NIH Grant for Sickle Cell Anemia Testing Device

Project Leader Umut Gurkan
CWRU researchers received a $2 million grant from the National Institutes of Health fordevelopment and testing of a blood adhesion monitor for sickle cell patients. The monitor is being developed with the intention for at home use with the hope that it will be similar to insulin monitors, both in size and usefulness, in the patients management of the disease. 

The need for a device of this nature comes from the random crises an individual with sickle cell anemia can face. Having a monitoring device may allow them to know when they are in danger of having a crises. This gives them time to receive treatment to prevent the crises, ultimately lowering the amount of longer hospitals stays and reducing the patients' stress and suffering. 

The exact mechanics of the device have not yet been finalized as some of the mechanisms of sickle cell disease are still unknown. Researchers hope to understand these mechanisms and how they relate to the device before clinical trials begin in one year at University Hospitals and Rainbow Babies.

Umut Gurkan, associate professor of hematology and oncology at Case Western Reserve University, is the project leader for this research. In 2014, Gurkan received an annual pilot award from the CTSC for research on a device for early detection of sickle cell disease in newborns. 

Events Events
Save the Date:  1st Annual Cancer Disparities Symposium: Building Bridges to Address Cancer Disparities
Friday, March 17, 2017 | Cleveland, OH

The Case Comprehensive Cancer Center is excited to announce the inaugural Cancer Disparities Symposium: Building Bridges to Address Cancer Disparities. Understanding and addressing cancer disparities is complex and multi-faceted, and requires attention across the translational spectrum. This half-day event will showcase cutting-edge research, with a focus on reducing and eliminating disparities in cancer, going from bench-to-bedside-to-community and back. This important symposium will also feature two keynote addresses, including a key leader in our community, and an internationally-recognized cancer disparities researcher. We will promote the exchange of ideas and collaborative opportunities among scientists, clinicians, government, and community representatives.

Organizing Committee: Monica Webb Hooper, PhD, Cynthia Owusu, MD, MSc, Smitha Krishnamurthi, MD, Siran Koroukian, PhD, and Cancer Center Administration

Please save the date! More information to follow.

Seminar in Multidisciplinary Clinical and Translational Research
WRB 6136 from 12-1 pm

April 10, 2017 - Jim Werner, PhD, Associate Professor, Dept. of Family Medicine & Community Health, CWRU, will discuss "Practice-Based Research Networks: Essential Infrastructure for Translational Research"

For questions contact Angela Bowling (

CRSP 401 "Introduction to Clinical Research"
Application Deadline: May 15, 2017

Seminars will be held from July 5 - 27, 2017 in the mornings in the Wolstein Research Building.

If you would like to apply please read fully this informational flyer and the instructions for both Non-CRF applications and Non-Degree applications.

For questions contact Angela Bowling (

Comparative Effectiveness Research: From All Angles
May 18-19, 2017
Save the Date! OHRP Research Community Forum
September 6-7, 2017
Northern Kentucky Convention Center, Covington, KY

The Cincinnati CTSA will be hosting a two-day human subject protection forum consisting of an academic conference and an applied workshop relevant for institutional review board (IRB) members, IRB administrators, clinical investigators, research scientists and support staff, sponsors, contract research organizations, government regulators, and members of the research community.
Representatives from the Office of Human Research Protection (OHRP) and other federal agencies as well as research experts will provide perspectives and resources for interpreting and applying human subject protections in an evolving regulatory landscape.
Tracks include:
  •          Social/behavioral research
  •          Biomedical research
  •          Innovative research
  •          Regulatory landscape
  •          Community engagement
Registration information and full agenda coming soon!
Funding Funding Opportunities
Special Funding Opportunity

The Case Western Center for Reducing Health Disparities will be leading CWRU's application for an NIH-funded Specialized Center for Research on Minority Health and Health Disparities.

If you are interested in participating to the application, please contact Dr. Ash Sehgal (216-778-7728 or

Research Initiative Details
This Notice encourages investigators with expertise and insights into the science of health disparities, particularly the complex interplay between risk and protective factors acting at multiple levels across the life course, to begin to consider applying for this new FOA.

The FOA will encourage collaborative activities combining expertise in biomedical and behavioral research, research education, clinical and health services research, social science, environmental health science, population science, translational science, implementation science, and the science of community engagement. Each COE is expected to have a thematic focus in a specific scientific area that may include, but are not limited, to social determinants of health, men's health, women's health, maternal and child health, chronic disease prevention, environmental health disparities, precision medicine, health services and policy research. The COEs will be expected to work closely with community partners to facilitate development of programs that can be implemented in real-world settings to improve minority health and reduce health disparities.

Projects must include a focus on one or more NIH-designated health disparity populations, which include Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Asian Americans, Native Hawaiians and Other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities.

# NOT-TR-17-004

The purpose of this Notice is make modifications for PAR-15-172 " Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)" for the March 9, 2017, and subsequent due dates, and expand the list of high priority translational research opportunities to novel clinical trials of drugs that target shared molecular etiologies underlying multiple diseases.

Robert Wood Johnson Foundation - Health Policy and Law Research
Letter of Intent Due: March 10, 2017

The Robert Wood Johnson Foundation has issued a Call for Proposals for research projects that can help build an evidence base for policies that lead to a Culture of Health.

Through its Policies for Action: Policy and Law Research to Build a Culture of Health program, the foundation seeks to engage longstanding health and healthcare researchers, as well as experts in fields such as housing, education, transportation, and the built environment who have not worked in health before. The goal is to develop research that generates actionable evidence - data and information - that can guide legislators and other policy makers, public agencies, educators, advocates, community groups, and individuals in shaping health policy.

The research may examine established laws, regulations, and policies, as well as potential new policies and approaches, and should inform significant gaps in knowledge with respect to which policies can serve as levers to improve population health and well-being and achieve greater levels of health equity.

Preference will be given to innovative research that evaluates and addresses actionable policies focused on early childhood, or that have lifelong, even multigenerational benefits; are preventive rather than remedial; advance a community's own priorities; highlight collaboration between the public and private sectors, or innovations within the private sector; address people or places or systems that have been traditionally underserved or unattended; foster stability and continuity at the neighborhood, community, state, and/or federal levels; transform or bridge major service systems, such as between healthcare and public health systems, or other systems that influence health in communities, such as social services or education; and/or influence values and beliefs integral to a Culture of Health.

Applicants must be a public entity or nonprofit organizations that is tax-exempt under Section 501(c)(3) of the Internal Revenue Code and be based in the United States. Applications are welcome from interdisciplinary or cross-sectoral research teams; investigators from a variety of areas and disciplines, including but not limited to architecture, business, community planning, data scientists, economics, epidemiology, health policy, medicine, public health, social work, sociology; and urban planning and system engineers.

The program will award grants of up to $250,000 for up to two years.

Letter of Intent Deadline: March 10, 2017
Invited Proposal Deadline: June 16, 2017

For more information visit the RWJF website .

Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute at University Hospitals
Letter of Intent Due: March 17, 2017

The  Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute  at University Hospitals in Cleveland, Ohio are pleased to announce the request for proposals for the 2017 ADDF-Harrington Scholar Award.

The ADDF-Harrington Scholar Award supports research efforts that seek to prevent, treat, or cure Alzheimer's disease, related dementias and cognitive aging.

Letters of Intent are now being accepted.

Applicants have the opportunity to receive:
  • Funding up to $600,000 over two years
  • Drug development and project management support through the Harrington Discovery Institute's Innovation Support Center
Letter of Intent Deadline: March 17, 2017 (by midnight)

For more information visit the Harrington Discovery Institute website.

CHEST Foundation
Application Deadline: March 31, 2017

As the charitable foundation for the American College of Chest Physicians, the CHEST Foundation champions lung health by supporting clinical research, patient education, and community service, with more than 95 cents of every dollar raised by the foundation going toward advancing its mission-based programming. Since 1996, the foundation has awarded more than a thousand grants totaling over $10 million for clinical research and community-service projects.

In 2017, the foundation will award one-year grants of up to $50,000 in support of research that addresses the clinical, population, or community engagement/health services aspects of chronic obstructive pulmonary disease and that has relevance to the prevention and/or reduction in morbidity or mortality associated with COPD.

To be eligible, applicants must be a licensed physician and member of CHEST in good standing at the time of application. Physicians-in-training (residents or fellows), other healthcare professionals, or clinical researchers with relevant experience also are eligible to apply. Although applicants may be in the later stages of their career, special consideration will be given to early-career investigators and applicants. Nonprofit organizations and institutions also are eligible to apply.

Application Deadline: March 31, 2017

For more information 

NSF: Advanced Biomanufacturing of Therapeutic Cells
Application Deadline: April 17, 2017

In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, Alzheimer's, Parkinson's, and Crohn's disease. Production of therapeutic cells is currently expensive and, therefore, cost prohibitive for the large number of people who might benefit from these treatments. The overarching goal of this Advanced Biomanufacturing of Therapeutic Cells (ABTC) solicitation is to catalyze well-integrated interdisciplinary research to understand, design, and control cell manufacturing systems and processes that will enable reproducible, cost-effective, and high-quality production of cells with predictable performance for the identified therapeutic function.

Application Deadline: April 17, 2017

For more information visit the Grants.Gov website.

Sigma Theta Tau International
Application Deadline: May 1, 2017

Founded in 1922, Sigma Theta Tau International supports the learning, knowledge, and professional development of nurses working to make a difference in global health.

To that end, the organization is inviting applications from registered nurses for its Global Nursing Research Grant program. Through the program, a single grant of up to $10,000 is awarded annually to encourage nurses to focus on responding to health disparities globally. 

To be eligible, the principal investigator(s) should be a registered nurse (or country equivalent) with a current license and have at least a master's in nursing (or country equivalent). Preference will be given to Sigma Theta Tau members. 

Application Deadline: May 1, 2017

For more information visit the STTI website.

Centers for Disease Control - Racial and Ethnic Approaches to Community Health (REACH)
Application Deadline: May 23, 2017

Chronic diseases and their outcomes disproportionately impact racial and ethnic populations including African Americans/Blacks, Hispanic Americans, Asian Americans, Native Hawaiian/Other Pacific Islanders, American Indians and Alaska Natives. Attention to improving the access to high-quality nutrition, opportunities for physical activity and providing a smoke-free environment for young children are critical steps in reducing health disparities. The purpose of this FOA is to provide communities the opportunity to improve poor health, prevent chronic diseases and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease. Eligible applicants are unrestricted. Grant recipients will receive up to $1 million.

Application Deadline: May 23, 2017

For more information visit the Grants.Gov website.

Little Giraffe Foundation
Application Deadline: July 14, 2017

The  Little Giraffe Foundation  is dedicated to funding neonatal research and supporting patients and parents of the NICU. The foundation is accepting Letters of Intent for 2017.

Grants of up to $10,000 will be awarded to qualified scientists, doctors, and nurses at universities, hospitals, and research institutions in support of research that addresses both the long-term and immediate health needs caused by premature birth as well as the causes of premature birth and ways to prevent it. Research subjects appropriate for support include basic biological processes governing development, genetics, clinical studies, studies of reproductive health, environmental toxicology, and social and behavioral studies. 

Letter of Intent Deadline: July 14, 2017

For more information visit the Little Giraffe website.

Special Funding Opportunities
Multiple Deadlines

Technical Assistance Videocast for RFA RM-16-019 "NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)"

NINDS Efficacy Clinical Trials (U01)

NINDS Exploratory Clinical Trials (R01)

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

NINR Clinical Trial Planning Grant (R34)

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) 

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) 

NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)

NIH-Industry Program Opportunities
Multiple Deadlines

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)
  • National Center for Advancing Translational Sciences
  • Application Receipt Date(s): April 17, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) 


  • National Center for Advancing Translational Sciences
  • National Institute of Dental and Craniofacial Research
  • Application Receipt Date(s): September 15, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) 


  • National Center for Advancing Translational Sciences
  • National Institute of Dental and Craniofacial Research
  • Application Receipt Date(s): September 15, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No Late applications will be accepted for this FOA. 
NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18)


  • National Center for Advancing Translational Sciences
  • Application Receipt Date(s): April 14, 2017
Department of Defense
Multiple Deadlines

The Department of Defense has announced the following new funding opportunity:  

Department of the Army - USAMRAA

Pandemic Prevention Platform (P3)
Have you explored Pure yet?

Check out Pure Experts, a directory of researcher expertise that enables collaboration among researchers! For more information on Pure, see the Pure Brochure.

Also be sure to contact our Research Concierge Service for all CTSC and research-related queries.

Researchers: Register for an
NIH has now adopted the ORCID ID, a free, open-source unique identifing number.  Learn more about ORCID.  It is also recommended that researchers link their ORCID ID to their CV in NIH's SciENcv, which creates a current, customizable biosketch on NIH grant form pages for any NIH grant.  If you would like to learn more about how to register and link your ORCID number, please contact: Clara Pelfrey, Evaluation Director at or (216) 368-6478.

Like us on Facebook    Follow us on Twitter    View our profile on LinkedIn